Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Villard

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
Swiss Medical Weekly|December 22, 2006
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantationSylvie Ferrari-Lacraz, Vincent Aubert, Leo Buhler, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistanceNicolas Papon, Thierry Noël, Martine Florent, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2005
Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivityFlorence Bettens, Jean-Marie Tiercy, Nathalie Campanile, et al.
The Pharmacogenomics Journal|January 5, 2018
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapineFrançois R Girardin, Antoine Poncet, Arnaud Perrier, et al.
Transplantation|August 1, 2020
Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric RecipientsVladimir L Cousin, Anne-Laure Rougemont, Laura Rubbia-Brandt, et al.
Transplantation|July 23, 2008
Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantationSylvie Ferrari-Lacraz, Thierry Berney, Philippe Morel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2002
Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiencyFranck Matheux, Aydan Ikinciogullari, David A Zapata, et al.
Leukemia|November 28, 2019
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantationStéphane Buhler, Florence Bettens, Carole Dantin, et al.
Rheumatology (Oxford, England)|December 8, 2020
Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the diseaseCéline Lamacchia, Zuleika Calderin Sollet, Delphine Courvoisier, et al.
Blood|December 14, 2002
Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptorsValerie Bigouret, Till Hoffmann, Lionel Arlettaz, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
Swiss Medical Weekly|December 22, 2006
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantationSylvie Ferrari-Lacraz, Vincent Aubert, Leo Buhler, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistanceNicolas Papon, Thierry Noël, Martine Florent, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 19, 2005
Microchimerism after liver transplantation: absence of rejection without abrogation of anti-donor cytotoxic T-lymphocyte-mediated alloreactivityFlorence Bettens, Jean-Marie Tiercy, Nathalie Campanile, et al.
The Pharmacogenomics Journal|January 5, 2018
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapineFrançois R Girardin, Antoine Poncet, Arnaud Perrier, et al.
Transplantation|August 1, 2020
Peripheral Donor-specific Antibodies Are Associated With Histology and Cellular Subtypes in Protocol Liver Biopsies of Pediatric RecipientsVladimir L Cousin, Anne-Laure Rougemont, Laura Rubbia-Brandt, et al.
Transplantation|July 23, 2008
Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantationSylvie Ferrari-Lacraz, Thierry Berney, Philippe Morel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2002
Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiencyFranck Matheux, Aydan Ikinciogullari, David A Zapata, et al.
Leukemia|November 28, 2019
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantationStéphane Buhler, Florence Bettens, Carole Dantin, et al.
Rheumatology (Oxford, England)|December 8, 2020
Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the diseaseCéline Lamacchia, Zuleika Calderin Sollet, Delphine Courvoisier, et al.
Blood|December 14, 2002
Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptorsValerie Bigouret, Till Hoffmann, Lionel Arlettaz, et al.
Pageof 11